Last reviewed · How we verify

Meperidine Injection

Centre hospitalier de l'Université de Montréal (CHUM) · Phase 3 active Small molecule

Meperidine is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia and sedation.

Meperidine is a synthetic opioid agonist that binds to mu opioid receptors in the central nervous system to produce analgesia and sedation. Used for Moderate to severe acute pain, Perioperative pain management.

At a glance

Generic nameMeperidine Injection
Also known asdemerol
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Drug classOpioid analgesic
TargetMu opioid receptor
ModalitySmall molecule
Therapeutic areaPain Management
PhasePhase 3

Mechanism of action

Meperidine acts as a mu opioid receptor agonist, blocking pain signal transmission in the spinal cord and brain. It also has weak monoamine oxidase inhibitor and local anesthetic properties. The drug is commonly used for moderate to severe acute pain management in hospital settings.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results